Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Chief Medical Officer +44 (0)203 763 9484
admin@pulmocide.com


Senior Medical Director of Clinical Development is +44 (0) 203 763 9484
admin@pulmocide.com


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)

Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)

Recruiting

Open to: ALL

Age: 18.0 - N/A

Medical Conditions

Aspergillosis
Pulmonary Aspergillosis
Invasive Pulmonary Aspergillosis


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


To assess the safety and efficacy of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory IPA

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jun 2022 Nov 2025

INTERVENTIONAL

Intervention Type : DRUG
Intervention Description : Sterile aqueous liquid for Nebulization

Intervention Arm Group : PC945;

Intervention Type : DRUG
Intervention Description : Sterile aqueous liquid for Nebulization

Intervention Arm Group : Placebo;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Clinical Research Site 065
    Cambridge
    CB20AY
  • Clinical Research Site 066
    Harefield
    UB96JH
  • Clinical Research Site 063
    London
    SE5 9RS
  • Clinical Research Site 062
    London
    SW170QT
  • Clinical Research Site 064
    London
    W120HS
  • Clinical Research Site 067
    Manchester
    M23 9QZ

Senior Medical Director of Clinical Development is +44 (0) 203 763 9484
admin@pulmocide.com


Chief Medical Officer +44 (0)203 763 9484
admin@pulmocide.com



The study is sponsored by Pulmocide Ltd




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT05238116
Last updated 02 December 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.